|
1
|
Raab GT, O'Neil DS, Kiran RP, Feingold DL, Lee-Kong SA, Horowitz DP, Neugut AI. Elevation of Serum CEA in Patients with Squamous Cell Carcinoma of the Anus. Cancer Invest 2019; 37:288-292. [PMID: 31319725 DOI: 10.1080/07357907.2019.1636388] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The proportion of anal cancer cases that produce elevated carcinoembryonic antigen (CEA) levels is not well described in the medical literature. In this study, we used electronic health record data from a single urban cancer center to identify patients from 2004-2018 with anal cancer who have also had a pre-initial treatment CEA measurement. We identified 40 patients who met our eligibility criteria. Of those, 11 (27.5%) had an elevated pretreatment CEA. Elevated CEA was not associated with any of the clinical or demographic covariates; however, three out of five patients with a recurrence had an elevated CEA.
Collapse
Affiliation(s)
- Gabriel T Raab
- Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA
| | - Daniel S O'Neil
- Department of Medicine, College of Physicians and Surgeons, Columbia University , New York , New York , USA
| | - Ravi P Kiran
- Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA.,Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University , New York , New York , USA.,Department of Surgery, College of Physicians and Surgeons, Columbia University , New York , New York , USA
| | - Daniel L Feingold
- Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University , New York , New York , USA.,Department of Surgery, College of Physicians and Surgeons, Columbia University , New York , New York , USA
| | - Steven A Lee-Kong
- Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University , New York , New York , USA.,Department of Surgery, College of Physicians and Surgeons, Columbia University , New York , New York , USA
| | - David P Horowitz
- Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University , New York , New York , USA.,Department of Radiation Oncology, Columbia University College of Physicians and Surgeons , New York , New York , USA
| | - Alfred I Neugut
- Department of Epidemiology, Mailman School of Public Health, Columbia University , New York , New York , USA.,Department of Medicine, College of Physicians and Surgeons, Columbia University , New York , New York , USA.,Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University , New York , New York , USA
| |
Collapse
|
|
2
|
Meillan N, Huguet F, Peiffert D. [Follow-up after radiotherapy of anal canal carcinoma]. Cancer Radiother 2015; 19:610-5. [PMID: 26323891 DOI: 10.1016/j.canrad.2015.06.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Revised: 06/10/2015] [Accepted: 06/12/2015] [Indexed: 01/11/2023]
Abstract
Anal canal carcinoma is a rare and curable disease for which the standard of care is radiation therapy with concurrent 5-fluoro-uracil and mitomycine-based chemotherapy. Post-treatment follow-up however is rather poorly defined. This article offers a review of the various post-treatment surveillance options both for early diagnosis of relapse and care for late treatment effects. While follow-up remains mostly clinical, we will discuss morphologic (endorectal echoendoscopy, pelvic magnetic resonance imaging, tomodensitometry and positron emission tomography) and biologic (squamous cell carcinoma antigen and pathology) follow-up so as to determine their diagnostic and prognostic value.
Collapse
Affiliation(s)
- N Meillan
- Service d'oncologie radiothérapie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
| | - F Huguet
- Service d'oncologie radiothérapie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - D Peiffert
- Institut de cancérologie de Lorraine (Alexis-Vautrin), 6, avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy cedex, France
| |
Collapse
|